<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">CTJ</journal-id>
<journal-id journal-id-type="hwp">spctj</journal-id>
<journal-id journal-id-type="nlm-ta">Clin Trials</journal-id>
<journal-title>Clinical Trials</journal-title>
<issn pub-type="ppub">1740-7745</issn>
<issn pub-type="epub">1740-7753</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1740774512464831</article-id>
<article-id pub-id-type="publisher-id">10.1177_1740774512464831</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Accrual by groups in trials with discrete-time survival endpoints</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Jóźwiak</surname><given-names>Katarzyna</given-names></name>
</contrib>
<contrib contrib-type="author">
<name><surname>Moerbeek</surname><given-names>Mirjam</given-names></name>
</contrib>
<aff id="aff1-1740774512464831">Department of Methodology and Statistics, Utrecht University, Utrecht, The Netherlands</aff>
</contrib-group>
<author-notes>
<corresp id="corresp1-1740774512464831">Katarzyna Jóźwiak, Department of Methodology and Statistics, Utrecht University, PO Box 80140, 3508 TC Utrecht, The Netherlands. Email: <email>k.jozwiak@uu.nl</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>2</month>
<year>2013</year>
</pub-date>
<volume>10</volume>
<issue>1</issue>
<fpage>32</fpage>
<lpage>42</lpage>
<permissions>
<copyright-statement>© The Author(s), 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">The Society for Clinical Trials</copyright-holder>
</permissions>
<abstract>
<sec id="section1-1740774512464831">
<title>Background</title>
<p>In many fields of science, event status is often recorded in intervals or at discrete points in time and can be investigated in experimental settings. Conducting such trials requires thorough planning before they are actually performed.</p>
</sec>
<sec id="section2-1740774512464831">
<title>Purpose</title>
<p>To investigate accrual by groups in a trial with discrete-time survival endpoints and to describe how to choose the number of accrual groups, the size of the accrual groups, and the duration of the trial to achieve a sufficient power level.</p>
</sec>
<sec id="section3-1740774512464831">
<title>Methods</title>
<p>In trials with multiple time periods, the event status is recorded at the end of each period, but the event may occur at any time between the time points the measurements are taken. Therefore, time is recorded discretely, but the underlying process is continuous. To find the risk of event occurrence in each time interval, a continuous-time survival function is used and the generalized linear model is applied.</p>
</sec>
<sec id="section4-1740774512464831">
<title>Results</title>
<p>It is observed that the combination of the number of accrual groups, the size of the accrual groups, and the duration of the trial that gives a sufficient power level depends on the shape of the continuous-time survival function, the proportion of subjects who have experienced the event after a fixed number of time periods, and the size of the treatment effect.</p>
</sec>
<sec id="section5-1740774512464831">
<title>Limitations</title>
<p>The results of the study are only presented graphically, because there is no simple closed-form expression for finding the variance of the treatment effect. The authors provide MATLAB software to perform the power calculations.</p>
</sec>
<sec id="section6-1740774512464831">
<title>Conclusions</title>
<p>More subjects should be recruited in each accrual group or more accrual groups should be included if the effect size or the proportion of the subjects who have experienced the event after a fixed number of time periods decreases, or the probability of the event occurrence is concentrated toward the end of the study duration.</p>
</sec>
</abstract>
</article-meta>
</front>
<body>
<sec id="section7-1740774512464831" sec-type="intro">
<title>Introduction</title>
<p>A longitudinal trial involves observing the same group of individuals over time, which allows to identify changes or differences that occur in time and to examine the causations of these changes or differences. This type of trial is usually conducted when the occurrence and timing of life events are studied, for example, when smoking initiation is investigated. Studies where researchers are interested ‘whether’ and/or ‘when’ subjects experience an event can be examined using survival analysis techniques. In such studies, time can be measured continuously like in days, hours, minutes, and usually the exact time of the event occurrence is registered. Data of this type can be analyzed using continuous-time survival methods, where the most popular model is the Cox model [<xref ref-type="bibr" rid="bibr1-1740774512464831">1</xref>]. Time can also be measured discretely, like in decades, years, or months when the event can only occur at particular points in time or when the measurements can only be taken at particular time points. Such data are often known as interval-censored data when time is considered as meaningful discrete intervals, such as ages or grades. The events may occur at any time during these intervals, but the measurements are taken at the end of each interval. It is also known as grouped-time data, when the event can occur at any time, but the measurement of time is coarse and the time of event occurrence is rounded off to the measurement time point. For discrete-time survival data, discrete-time survival analysis, with the generalized linear model (GLM) [<xref ref-type="bibr" rid="bibr2-1740774512464831">2</xref>] as the most commonly applied model, can be used.</p>
<p>The life events in longitudinal studies are very often investigated in experimental settings, where participants are split up into two or more conditions to compare the effectiveness of one or more new treatments relative to a standard treatment or no treatment at all. An example of a longitudinal trial with survival endpoints is presented by Storr <italic>et al</italic>. [<xref ref-type="bibr" rid="bibr3-1740774512464831">3</xref>] who investigated the onset of tobacco smoking. In this study, participants are followed over 6 years and measurements are taken once a year. There are three treatment conditions: a classroom-centered intervention group, a family–school partnership intervention group, and a control group.</p>
<p>If a treatment has an effect, researchers would like to detect it with a large probability. This probability is called the statistical power, and it depends mainly on the sample size. If an insufficient number of subjects is recruited, the treatment effect might not be observed. On the other hand, if too many subjects are recruited, it may be a waste of the researchers’ and participants’ time and money. Moreover, the power in longitudinal trials also depends on the number of measurements that are taken [<xref ref-type="bibr" rid="bibr4-1740774512464831">4</xref><xref ref-type="bibr" rid="bibr5-1740774512464831"/>–<xref ref-type="bibr" rid="bibr6-1740774512464831">6</xref>].</p>
<p>Experimental trials with longitudinal designs are conducted in different ways. One of the possibilities is that all participants are recruited at the same time, and they are followed for the same length of time. For instance, when school grades of first heterosexual intercourse for boys are investigated, the study starts at the same time for all observed boys, for example, in the first grade at secondary school [<xref ref-type="bibr" rid="bibr7-1740774512464831">7</xref>]. Another possibility is that participants are recruited at different times, for example, patients receive a treatment immediately after the disease has been diagnosed and of course the diagnosis times vary for various patients. In such cases, researchers usually have prespecified time for finishing their study, so participants can be followed until some point in time. Therefore, in trials of this type, various subjects are followed for different length of time because the ones who enter the study later are observed for a shorter length of time. The time in which participants can join the study is called the accrual time, and the average number of recruited participants per time interval is called the accrual rate.</p>
<p>In the statistical literature, one can easily find studies on how to choose the accrual rate, duration of accrual time, and follow-up time for trials with continuous-time survival outcomes. This issue is presented, among others, by Pasternack and Gilbert [<xref ref-type="bibr" rid="bibr8-1740774512464831">8</xref>], George and Desu [<xref ref-type="bibr" rid="bibr9-1740774512464831">9</xref>], Rubinstein <italic>et al</italic>. [<xref ref-type="bibr" rid="bibr10-1740774512464831">10</xref>], Schoenfeld and Richter [<xref ref-type="bibr" rid="bibr11-1740774512464831">11</xref>], Morgan [<xref ref-type="bibr" rid="bibr12-1740774512464831">12</xref>], and Lachin and Foulkes [<xref ref-type="bibr" rid="bibr13-1740774512464831">13</xref>], and they present designs that are chosen in such a way that a specified level of statistical power is achieved. However, in the literature, there are no such studies for trials with discrete-time survival endpoints. Therefore, in this article, we present how to plan trials where subjects enter the study at different points in time and they are observed in time intervals. Subjects who enter the study in the same recruitment period belong to the same accrual group, and we investigate designs for various numbers of accrual groups and various accrual group sizes. We consider varying durations of the study, treatment effect, and proportion of subjects who have experienced the event after a fixed number of time intervals. Moreover, we take hazard probabilities that are constant, increasing, or decreasing across time periods into account, and we also take an attrition rate into consideration. First, we present the general model that is used in our study, and we describe how to calculate the statistical power. Next, we show our results and give a hypothetical example to illustrate our method.</p>
</sec>
<sec id="section8-1740774512464831">
<title>Model</title>
<p>In this section, the general model with discrete-time survival endpoints is described. The method we use is very well explained by Singer and Willett [<xref ref-type="bibr" rid="bibr7-1740774512464831">7</xref>] and was proposed by Cox [<xref ref-type="bibr" rid="bibr1-1740774512464831">1</xref>]. It is further discussed by Kalbfleisch and Prentice [<xref ref-type="bibr" rid="bibr14-1740774512464831">14</xref>] (sections 2.4 and 4.8). Another model is given by Prentice and Gloeckler [<xref ref-type="bibr" rid="bibr15-1740774512464831">15</xref>].</p>
<p>We consider trials with two treatment conditions, a control and an experimental condition that are equally sized at baseline. The trial begins when the first participant is recruited, and he or she is followed for at most <italic>p</italic> time periods. These <italic>p</italic> time periods are of equal width that is fixed beforehand, and the trial ends when these <italic>p</italic> periods have elapsed, that is, when the prespecified endpoint of the study is reached. Other participants may enter the study at any point in time during the recruitment time, but they are followed until the same prespecified endpoint. Since all subjects are followed until this endpoint is reached, persons who enter the study later are followed for a shorter length of the follow-up time. In other words, for these subjects, the measurements at the beginning of the study are missing by design. The participants may leave the study before the end of the follow-up time, when the event or some other unforeseen reason of leaving the study occurs. We call the time that subjects stay in the study the ‘observation time’. We want the reader to distinguish that we use three different indications of time: duration of the study, follow-up time, and observation time.</p>
<p>The length of each period is the same for all persons, but the location of the measurement points depends on the time of recruitment. As a result, measurements are taken at different points in time for different subjects, and the number of follow-up time periods varies per subject. The subjects who are followed for the same number of time periods belong to the same accrual group. The first accrual group is followed for <italic>p</italic> periods, the second accrual group is followed for <italic>p −</italic> 1 periods, the third accrual group is followed for <italic>p −</italic> 2 periods, and so on. An accrual group size is the number of the subjects who belong to the same accrual group.</p>
<p>The accrual of subjects in such a trial is presented in <xref ref-type="fig" rid="fig1-1740774512464831">Figure 1</xref>, where a trial with <italic>p</italic> = 6 time periods and <italic>m</italic> = 3 accrual groups is illustrated. Subject 1 is followed for 6 periods, and he or she belongs to the first accrual group; subjects 2, 3, and 5 are followed for 5 periods, and they belong to the second accrual group; and subject 4 is followed for 4 periods, and he or she belongs to the third accrual group. Although subjects 2 and 3 are actually observed for a longer time, the event occurrence is not registered after the end of the fifth time period since the next measurement point would be after the end of the study duration. Event occurrence is represented by ‘x’ and attrition by ‘Δ’. The time point of entering the study is indicated by ‘○’, the end of the study by ‘□’, and the measurement points by ‘|’. The solid lines show the observation time for the individuals, and the dashed lines illustrate the additional time that the individual could have been followed-up if he or she had not left the trial due to event occurrence or other reasons. For example, the first subject experiences the event in the second follow-up period, while the fourth subject leaves the study due to an unforeseen reason, without experiencing the event, during the fourth follow-up period.</p>
<fig id="fig1-1740774512464831" position="float">
<label>Figure 1.</label>
<caption>
<p>Accrual of five subjects in a longitudinal trial of fixed duration (‘x’: event occurrence, ‘Δ’: attrition, ‘○’: entering the study, ‘□’: end of the study, ‘|’ measurement point, —: observation time, - - -: additional time).</p>
</caption>
<graphic xlink:href="10.1177_1740774512464831-fig1.tif"/>
</fig>
<p>At the end of each time period, the event status is observed, and it is represented by a binary response variable. The outcome for the <italic>i</italic>th subject from the <italic>j</italic>th (<italic>j</italic> = 1, …, <italic>m</italic>) accrual group in the <italic>k</italic>th (<italic>k</italic> = 1, …, <italic>p − j+</italic>1) period is noted as <inline-formula id="inline-formula1-1740774512464831"><mml:math display="inline" id="math1-1740774512464831"><mml:mrow><mml:msub><mml:mrow><mml:mi>Y</mml:mi></mml:mrow><mml:mrow><mml:mi>ijk</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>, and it takes the value 1, if the event occurs, or 0, if it does not occur. The outcomes <inline-formula id="inline-formula2-1740774512464831"><mml:math display="inline" id="math2-1740774512464831"><mml:mrow><mml:msub><mml:mrow><mml:mi>Y</mml:mi></mml:mrow><mml:mrow><mml:mi>ijk</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> are assumed to be independently and identically distributed with hazard probabilities <inline-formula id="inline-formula3-1740774512464831"><mml:math display="inline" id="math3-1740774512464831"><mml:mrow><mml:mi>h</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>ijk</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula> that are the <italic>conditional</italic> probabilities that the event has not occurred in previous periods: <inline-formula id="inline-formula4-1740774512464831"><mml:math display="inline" id="math4-1740774512464831"><mml:mrow><mml:mi>h</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>ijk</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mi>P</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mrow><mml:mi>T</mml:mi></mml:mrow><mml:mrow><mml:mi>ijk</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mi>k</mml:mi><mml:mo stretchy="false">|</mml:mo><mml:msub><mml:mrow><mml:mi>T</mml:mi></mml:mrow><mml:mrow><mml:mi>ijk</mml:mi></mml:mrow></mml:msub><mml:mo>≥</mml:mo><mml:mi>k</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula>. Here, <inline-formula id="inline-formula5-1740774512464831"><mml:math display="inline" id="math5-1740774512464831"><mml:mrow><mml:msub><mml:mrow><mml:mi>T</mml:mi></mml:mrow><mml:mrow><mml:mi>ijk</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> is a discrete variable for time. <inline-formula id="inline-formula6-1740774512464831"><mml:math display="inline" id="math6-1740774512464831"><mml:mrow><mml:msub><mml:mrow><mml:mi>Y</mml:mi></mml:mrow><mml:mrow><mml:mi>ijk</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> is used for analysis until time period <italic>k</italic> if the <italic>i</italic>th subject either experiences the event or drops out from the trial in the <italic>k</italic>th time interval or until time <italic>p</italic> if the subject completes the trial experiencing the event in the <italic>p</italic>th time interval or does not experience the event during the course of the trial. The outcome is presented in the person–period data set that includes observations (i.e., lines in a data matrix) of each subject <italic>i</italic> until and including the time interval subject <italic>i</italic> either experiences the event or gets censored. As the number of observations <inline-formula id="inline-formula7-1740774512464831"><mml:math display="inline" id="math7-1740774512464831"><mml:mrow><mml:msub><mml:mrow><mml:mi>Y</mml:mi></mml:mrow><mml:mrow><mml:mi>ijk</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> varies across subjects, care should be taken in presenting the person–period data. In the person–period data set, there are multiple records for each person, and instead of modeling a single random variable time, we are interested in modeling the conditional probability of event occurrence for each person in each of his or her time periods of risk. The conditioning depends upon the individual surviving until each particular time period, and therefore, we can assume that all records in the person–period data set are <italic>conditionally</italic> independent (section 11.3.2 in Singer and Willet [<xref ref-type="bibr" rid="bibr7-1740774512464831">7</xref>]). What is more, when noninformative attrition is assumed (i.e., missingness at random), the noncensored individuals do not differ systematically from the censored individuals, which implies that those subjects who remain in the study are representative of everyone who would have remained in the study if there had been no censoring. In that case, a GLM with iteratively reweighted least squares estimator is an appropriate model for analysis.</p>
<p>The risk of experiencing the event can be found in each time period, and it depends not only on the duration of the period but also on the underlying continuous-time survival function that is defined as <italic>S</italic>(<italic>t</italic>) = <italic>P</italic>(<italic>T</italic> &gt; <italic>t</italic>), where <italic>T</italic> is a continuous random variable for time. The survival in discrete-time is calculated by evaluating <italic>S</italic>(<italic>t</italic>) at time points <inline-formula id="inline-formula8-1740774512464831"><mml:math display="inline" id="math8-1740774512464831"><mml:mrow><mml:mi>t</mml:mi><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>, where <inline-formula id="inline-formula9-1740774512464831"><mml:math display="inline" id="math9-1740774512464831"><mml:mrow><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mi>k</mml:mi><mml:mo stretchy="false">/</mml:mo><mml:mi>p</mml:mi></mml:mrow></mml:math></inline-formula> determines the end of time period <italic>k</italic>. Then, the hazard probability is obtained as a conditional probability <inline-formula id="inline-formula10-1740774512464831"><mml:math display="inline" id="math10-1740774512464831"><mml:mrow><mml:mi>h</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mi>S</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo><mml:mo>−</mml:mo><mml:mi>S</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">/</mml:mo><mml:mi>S</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula>.</p>
<p>Using the GLM with the logit link function, the hazard probability for subject <italic>i</italic> from the <italic>j</italic>th accrual group in period <italic>k</italic> is modeled in the following way</p>
<p>
<disp-formula id="disp-formula1-1740774512464831">
<label>(1)</label>
<mml:math display="block" id="math11-1740774512464831">
<mml:mrow>
<mml:mi>g</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>h</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>t</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>ijk</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>=</mml:mo>
<mml:mtext>logit</mml:mtext>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>h</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>t</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>ijk</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>=</mml:mo>
<mml:mi>log</mml:mi>
<mml:mfrac>
<mml:mrow>
<mml:mi>h</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>t</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>ijk</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
<mml:mrow>
<mml:mn>1</mml:mn>
<mml:mo>−</mml:mo>
<mml:mi>h</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>t</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>ijk</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:mfrac>
<mml:mo>=</mml:mo>
<mml:munderover>
<mml:mo>∑</mml:mo>
<mml:mrow>
<mml:mi>k</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
<mml:mrow>
<mml:mi>p</mml:mi>
<mml:mo>−</mml:mo>
<mml:mi>j</mml:mi>
<mml:mo>+</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:munderover>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>α</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>jk</mml:mi>
</mml:mrow>
</mml:msub>
<mml:msub>
<mml:mrow>
<mml:mi>D</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>ijk</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>+</mml:mo>
<mml:mi>β</mml:mi>
<mml:msub>
<mml:mrow>
<mml:mi>Z</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>ij</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:math>
<graphic alternate-form-of="disp-formula1-1740774512464831" xlink:href="10.1177_1740774512464831-eq1.tif"/>
</disp-formula>
</p>
<p>The variable <inline-formula id="inline-formula11-1740774512464831"><mml:math display="inline" id="math12-1740774512464831"><mml:mrow><mml:msub><mml:mrow><mml:mi>Z</mml:mi></mml:mrow><mml:mrow><mml:mi>ij</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> corresponds to the treatment condition: <inline-formula id="inline-formula12-1740774512464831"><mml:math display="inline" id="math13-1740774512464831"><mml:mrow><mml:msub><mml:mrow><mml:mi>Z</mml:mi></mml:mrow><mml:mrow><mml:mi>ij</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></inline-formula> for the accrual group <italic>j</italic> in the control condition, and <inline-formula id="inline-formula13-1740774512464831"><mml:math display="inline" id="math14-1740774512464831"><mml:mrow><mml:msub><mml:mrow><mml:mi>Z</mml:mi></mml:mrow><mml:mrow><mml:mi>ij</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math></inline-formula> for the accrual group <italic>j</italic> in the experimental condition. The parameter <italic>β</italic> is the treatment effect on the logit scale, and it is assumed to be constant across <italic>p</italic> time periods and across <italic>m</italic> accrual groups. <inline-formula id="inline-formula14-1740774512464831"><mml:math display="inline" id="math15-1740774512464831"><mml:mrow><mml:msub><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mrow><mml:mi>ijk</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> is a dummy variable that takes value 1 in the <italic>k</italic>th period and 0 in all the other periods. <inline-formula id="inline-formula15-1740774512464831"><mml:math display="inline" id="math16-1740774512464831"><mml:mrow><mml:msup><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mrow><mml:mi>α</mml:mi></mml:mrow><mml:mrow><mml:mi>jk</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula> represents the baseline hazard for accrual group <italic>j</italic> in time period <italic>k</italic>. Moreover, <italic>β</italic> is the difference on the logit scale between hazard probabilities in the two treatment conditions. We assume that all accrual groups from the same treatment condition follow the same underlying continuous-time survival function: <inline-formula id="inline-formula16-1740774512464831"><mml:math display="inline" id="math17-1740774512464831"><mml:mrow><mml:msub><mml:mrow><mml:mi>α</mml:mi></mml:mrow><mml:mrow><mml:mn>11</mml:mn></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>α</mml:mi></mml:mrow><mml:mrow><mml:mn>21</mml:mn></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mo>…</mml:mo><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>α</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mo>,</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:mspace width="0.25em"/><mml:msub><mml:mrow><mml:mi>α</mml:mi></mml:mrow><mml:mrow><mml:mn>12</mml:mn></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>α</mml:mi></mml:mrow><mml:mrow><mml:mn>22</mml:mn></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mo>…</mml:mo><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>α</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mo>,</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:mspace width="0.25em"/><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:mspace width="0.25em"/><mml:mtext>and</mml:mtext><mml:mspace width="0.25em"/><mml:msub><mml:mrow><mml:mi>α</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mi>p</mml:mi><mml:mo>−</mml:mo><mml:mi>m</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>α</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn><mml:mo>,</mml:mo><mml:mi>p</mml:mi><mml:mo>−</mml:mo><mml:mi>m</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mo>…</mml:mo><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>α</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mo>,</mml:mo><mml:mi>p</mml:mi><mml:mo>−</mml:mo><mml:mi>m</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>.</p>
<p><xref ref-type="disp-formula" rid="disp-formula1-1740774512464831">Equation (1)</xref> can be represented using matrix notation</p>
<p>
<disp-formula id="disp-formula2-1740774512464831">
<label>(2)</label>
<mml:math display="block" id="math18-1740774512464831">
<mml:mrow>
<mml:mi>g</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>h</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>t</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>=</mml:mo>
<mml:mi>X</mml:mi>
<mml:mi>θ</mml:mi>
</mml:mrow>
</mml:math>
<graphic alternate-form-of="disp-formula2-1740774512464831" xlink:href="10.1177_1740774512464831-eq2.tif"/>
</disp-formula>
</p>
<p>and then, the probabilities of event occurrence are obtained by</p>
<p>
<disp-formula id="disp-formula3-1740774512464831">
<mml:math display="block" id="math19-1740774512464831">
<mml:mrow>
<mml:mi>h</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>t</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>=</mml:mo>
<mml:msup>
<mml:mrow>
<mml:mi>g</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mo>−</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:msup>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>X</mml:mi>
<mml:mi>θ</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:math>
<graphic alternate-form-of="disp-formula3-1740774512464831" xlink:href="10.1177_1740774512464831-eq3.tif"/>
</disp-formula>
</p>
<p><italic>h</italic>(<italic>t</italic>) is a vector of hazard probabilities <inline-formula id="inline-formula17-1740774512464831"><mml:math display="inline" id="math20-1740774512464831"><mml:mrow><mml:msub><mml:mrow><mml:mi>h</mml:mi></mml:mrow><mml:mrow><mml:mi>C</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>ijk</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula> and <inline-formula id="inline-formula18-1740774512464831"><mml:math display="inline" id="math21-1740774512464831"><mml:mrow><mml:msub><mml:mrow><mml:mi>h</mml:mi></mml:mrow><mml:mrow><mml:mi>E</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>ijk</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula> for all time periods and all subjects from the control and experimental condition, respectively. <italic>X</italic> is a design matrix that has (<italic>p+</italic>1) columns and <inline-formula id="inline-formula19-1740774512464831"><mml:math display="inline" id="math22-1740774512464831"><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:munderover><mml:mo>∑</mml:mo><mml:mrow><mml:mi>j</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>m</mml:mi></mml:mrow></mml:munderover><mml:munderover><mml:mo>∑</mml:mo><mml:mrow><mml:mi>k</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>p</mml:mi><mml:mo>−</mml:mo><mml:mi>j</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:munderover><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi>jk</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:munderover><mml:mo>∑</mml:mo><mml:mrow><mml:mi>j</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>m</mml:mi></mml:mrow></mml:munderover><mml:munderover><mml:mo>∑</mml:mo><mml:mrow><mml:mi>k</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>p</mml:mi><mml:mo>−</mml:mo><mml:mi>j</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:munderover><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:mi>jk</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> rows. <inline-formula id="inline-formula20-1740774512464831"><mml:math display="inline" id="math23-1740774512464831"><mml:mrow><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> and <inline-formula id="inline-formula21-1740774512464831"><mml:math display="inline" id="math24-1740774512464831"><mml:mrow><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> represent the number of subjects at baseline, in the control and the experimental condition for the <italic>j</italic>th accrual group, respectively, and <inline-formula id="inline-formula22-1740774512464831"><mml:math display="inline" id="math25-1740774512464831"><mml:mrow><mml:msub><mml:mrow><mml:mi>c</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>, where <inline-formula id="inline-formula23-1740774512464831"><mml:math display="inline" id="math26-1740774512464831"><mml:mrow><mml:msub><mml:mrow><mml:mi>c</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> is the <italic>j</italic>th accrual group size that is assumed to be constant across all accrual groups, that is, <inline-formula id="inline-formula24-1740774512464831"><mml:math display="inline" id="math27-1740774512464831"><mml:mrow><mml:msub><mml:mrow><mml:mi>c</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mi>c</mml:mi></mml:mrow></mml:math></inline-formula> for all <italic>j</italic>. <inline-formula id="inline-formula25-1740774512464831"><mml:math display="inline" id="math28-1740774512464831"><mml:mrow><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi>jk</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> and <inline-formula id="inline-formula26-1740774512464831"><mml:math display="inline" id="math29-1740774512464831"><mml:mrow><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:mi>jk</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> are the number of subjects from the <italic>j</italic>th accrual group entering the <italic>k</italic>th time interval. <inline-formula id="inline-formula27-1740774512464831"><mml:math display="inline" id="math30-1740774512464831"><mml:mrow><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi>jk</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> is calculated as follows: <inline-formula id="inline-formula28-1740774512464831"><mml:math display="inline" id="math31-1740774512464831"><mml:mrow><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi>jk</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi><mml:mo>,</mml:mo><mml:mi>k</mml:mi><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msub><mml:mrow><mml:mi>h</mml:mi></mml:mrow><mml:mrow><mml:mi>C</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula> and <inline-formula id="inline-formula29-1740774512464831"><mml:math display="inline" id="math32-1740774512464831"><mml:mrow><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:mi>jk</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> is obtained in a similar way: <inline-formula id="inline-formula30-1740774512464831"><mml:math display="inline" id="math33-1740774512464831"><mml:mrow><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:mi>jk</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi><mml:mo>,</mml:mo><mml:mi>k</mml:mi><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msub><mml:mrow><mml:mi>h</mml:mi></mml:mrow><mml:mrow><mml:mi>E</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula>, where <inline-formula id="inline-formula31-1740774512464831"><mml:math display="inline" id="math34-1740774512464831"><mml:mrow><mml:msub><mml:mrow><mml:mi>h</mml:mi></mml:mrow><mml:mrow><mml:mi>C</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula> and <inline-formula id="inline-formula32-1740774512464831"><mml:math display="inline" id="math35-1740774512464831"><mml:mrow><mml:msub><mml:mrow><mml:mi>h</mml:mi></mml:mrow><mml:mrow><mml:mi>E</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula> are hazard probabilities in the time period <italic>k</italic>. We do not use subscript <italic>i</italic> anymore for the hazard probabilities since all subjects in period <italic>k</italic> have the same risk of experiencing the event.</p>
<p>The data matrix is presented in the person–period format with independently and identically distributed observations <inline-formula id="inline-formula33-1740774512464831"><mml:math display="inline" id="math36-1740774512464831"><mml:mrow><mml:msub><mml:mrow><mml:mi>Y</mml:mi></mml:mrow><mml:mrow><mml:mi>ijk</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>. We observe heterogeneity since <inline-formula id="inline-formula34-1740774512464831"><mml:math display="inline" id="math37-1740774512464831"><mml:mrow><mml:mi>Var</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>h</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>ijk</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mi>h</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>ijk</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">[</mml:mo><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:mi>h</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>ijk</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">]</mml:mo></mml:mrow></mml:math></inline-formula> (given the logit link). For this reason, the vector of unknown parameters <inline-formula id="inline-formula35-1740774512464831"><mml:math display="inline" id="math38-1740774512464831"><mml:mrow><mml:mi>θ</mml:mi><mml:mo>=</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mrow><mml:mi>α</mml:mi></mml:mrow><mml:mrow><mml:mn>11</mml:mn></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi>α</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mi>p</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi>α</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi>α</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mo>,</mml:mo><mml:mi>p</mml:mi><mml:mo>−</mml:mo><mml:mi>m</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:mi>β</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>′</mml:mo></mml:mrow></mml:math></inline-formula> is estimated using the iteratively reweighted least squares estimator for GLMs with the following likelihood function</p>
<p>
<disp-formula id="disp-formula4-1740774512464831">
<mml:math display="block" id="math39-1740774512464831">
<mml:mrow>
<mml:mi>l</mml:mi>
<mml:mo>=</mml:mo>
<mml:munderover>
<mml:mo>Π</mml:mo>
<mml:mrow>
<mml:mi>i</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
<mml:mrow>
<mml:mi>n</mml:mi>
</mml:mrow>
</mml:munderover>
<mml:munderover>
<mml:mo>Π</mml:mo>
<mml:mrow>
<mml:mi>j</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
<mml:mrow>
<mml:mi>m</mml:mi>
</mml:mrow>
</mml:munderover>
<mml:munderover>
<mml:mo>Π</mml:mo>
<mml:mrow>
<mml:mi>k</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
<mml:mrow>
<mml:mi>p</mml:mi>
<mml:mo>−</mml:mo>
<mml:mi>j</mml:mi>
<mml:mo>+</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:munderover>
<mml:mi>h</mml:mi>
<mml:msup>
<mml:mrow>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>t</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>ijk</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi>Y</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>ijk</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:msup>
<mml:mo stretchy="false">(</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo>−</mml:mo>
<mml:mi>h</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>t</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>ijk</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:msup>
<mml:mrow>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
<mml:mrow>
<mml:mn>1</mml:mn>
<mml:mo>−</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>Y</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>ijk</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:msup>
</mml:mrow>
</mml:math>
<graphic alternate-form-of="disp-formula4-1740774512464831" xlink:href="10.1177_1740774512464831-eq4.tif"/>
</disp-formula>
</p>
<p>where <italic>n</italic> is the total number of observations. More details about this estimation method can be found in McCullagh and Nelder [<xref ref-type="bibr" rid="bibr2-1740774512464831">2</xref>], and in section 11.3 of Singer and Willett [<xref ref-type="bibr" rid="bibr7-1740774512464831">7</xref>]. Applying this approach, the estimated asymptotic covariance matrix of the estimator <inline-formula id="inline-formula36-1740774512464831"><mml:math display="inline" id="math40-1740774512464831"><mml:mrow><mml:mover><mml:mrow><mml:mi>θ</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula> is obtained by</p>
<p>
<disp-formula id="disp-formula5-1740774512464831">
<label>(3)</label>
<mml:math display="block" id="math41-1740774512464831">
<mml:mrow>
<mml:mover accent="true">
<mml:mrow>
<mml:mi>V</mml:mi>
<mml:mi>a</mml:mi>
<mml:mi>r</mml:mi>
</mml:mrow>
<mml:mo stretchy="true">^</mml:mo>
</mml:mover>
<mml:mo stretchy="false">(</mml:mo>
<mml:mover accent="true">
<mml:mi>θ</mml:mi>
<mml:mo>^</mml:mo>
</mml:mover>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>=</mml:mo>
<mml:msup>
<mml:mrow>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:msub>
<mml:msup>
<mml:mi>X</mml:mi>
<mml:mo>′</mml:mo>
</mml:msup>
<mml:mi>C</mml:mi>
</mml:msub>
<mml:msub>
<mml:mover accent="true">
<mml:mi>W</mml:mi>
<mml:mo>^</mml:mo>
</mml:mover>
<mml:mi>C</mml:mi>
</mml:msub>
<mml:msub>
<mml:mi>X</mml:mi>
<mml:mi>C</mml:mi>
</mml:msub>
<mml:mo>+</mml:mo>
<mml:msub>
<mml:msup>
<mml:mi>X</mml:mi>
<mml:mo>′</mml:mo>
</mml:msup>
<mml:mi>E</mml:mi>
</mml:msub>
<mml:msub>
<mml:mover accent="true">
<mml:mi>W</mml:mi>
<mml:mo>^</mml:mo>
</mml:mover>
<mml:mi>E</mml:mi>
</mml:msub>
<mml:msub>
<mml:mi>X</mml:mi>
<mml:mi>E</mml:mi>
</mml:msub>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:mrow>
<mml:mrow>
<mml:mo>−</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:msup>
<mml:mo>=</mml:mo>
<mml:msup>
<mml:mrow>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mstyle displaystyle="true">
<mml:munderover>
<mml:mo>∑</mml:mo>
<mml:mrow>
<mml:mi>j</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
<mml:mi>m</mml:mi>
</mml:munderover>
<mml:mrow>
<mml:mstyle displaystyle="true">
<mml:munderover>
<mml:mo>∑</mml:mo>
<mml:mrow>
<mml:mi>k</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
<mml:mrow>
<mml:mi>p</mml:mi>
<mml:mo>−</mml:mo>
<mml:mi>j</mml:mi>
<mml:mo>+</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:munderover>
<mml:mrow>
<mml:msub>
<mml:msup>
<mml:mi>X</mml:mi>
<mml:mo>′</mml:mo>
</mml:msup>
<mml:mrow>
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mrow>
<mml:mi>j</mml:mi>
<mml:mi>k</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:msub>
<mml:msub>
<mml:mover accent="true">
<mml:mi>W</mml:mi>
<mml:mo>^</mml:mo>
</mml:mover>
<mml:mrow>
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mi>k</mml:mi>
</mml:msub>
</mml:mrow>
</mml:msub>
<mml:msub>
<mml:mi>X</mml:mi>
<mml:mrow>
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mrow>
<mml:mi>j</mml:mi>
<mml:mi>k</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:msub>
<mml:msub>
<mml:mi>n</mml:mi>
<mml:mrow>
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mrow>
<mml:mi>j</mml:mi>
<mml:mi>k</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:mstyle>
</mml:mrow>
</mml:mstyle>
<mml:mo>+</mml:mo>
<mml:mstyle displaystyle="true">
<mml:munderover>
<mml:mo>∑</mml:mo>
<mml:mrow>
<mml:mi>j</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
<mml:mi>m</mml:mi>
</mml:munderover>
<mml:mrow>
<mml:mstyle displaystyle="true">
<mml:munderover>
<mml:mo>∑</mml:mo>
<mml:mrow>
<mml:mi>k</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
<mml:mrow>
<mml:mi>p</mml:mi>
<mml:mo>−</mml:mo>
<mml:mi>j</mml:mi>
<mml:mo>+</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:munderover>
<mml:mrow>
<mml:msub>
<mml:msup>
<mml:mi>X</mml:mi>
<mml:mo>′</mml:mo>
</mml:msup>
<mml:mrow>
<mml:msub>
<mml:mi>E</mml:mi>
<mml:mrow>
<mml:mi>j</mml:mi>
<mml:mi>k</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:msub>
<mml:msub>
<mml:mover accent="true">
<mml:mi>W</mml:mi>
<mml:mo>^</mml:mo>
</mml:mover>
<mml:mrow>
<mml:msub>
<mml:mi>E</mml:mi>
<mml:mi>k</mml:mi>
</mml:msub>
</mml:mrow>
</mml:msub>
<mml:msub>
<mml:mi>X</mml:mi>
<mml:mrow>
<mml:msub>
<mml:mi>E</mml:mi>
<mml:mrow>
<mml:mi>j</mml:mi>
<mml:mi>k</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:msub>
<mml:msub>
<mml:mi>n</mml:mi>
<mml:mrow>
<mml:msub>
<mml:mi>E</mml:mi>
<mml:mrow>
<mml:mi>j</mml:mi>
<mml:mi>k</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:mstyle>
</mml:mrow>
</mml:mstyle>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:mrow>
<mml:mrow>
<mml:mo>−</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:msup>
</mml:mrow>
</mml:math>
<graphic alternate-form-of="disp-formula5-1740774512464831" xlink:href="10.1177_1740774512464831-eq5.tif"/></disp-formula>
</p>
<p>where <inline-formula id="inline-formula37-1740774512464831"><mml:math display="inline" id="math42-1740774512464831"><mml:mrow><mml:msub><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mi>C</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> and <inline-formula id="inline-formula38-1740774512464831"><mml:math display="inline" id="math43-1740774512464831"><mml:mrow><mml:msub><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mi>E</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> are design matrices with <italic>p +</italic> 1 columns for the control and experimental condition, respectively. <inline-formula id="inline-formula39-1740774512464831"><mml:math display="inline" id="math44-1740774512464831"><mml:mrow><mml:msub><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mi>C</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> has <inline-formula id="inline-formula40-1740774512464831"><mml:math display="inline" id="math45-1740774512464831"><mml:mrow><mml:munderover><mml:mo>∑</mml:mo><mml:mrow><mml:mi>j</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>m</mml:mi></mml:mrow></mml:munderover><mml:munderover><mml:mo>∑</mml:mo><mml:mrow><mml:mi>k</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>p</mml:mi><mml:mo>−</mml:mo><mml:mi>j</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:munderover><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi>jk</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> rows and <inline-formula id="inline-formula41-1740774512464831"><mml:math display="inline" id="math46-1740774512464831"><mml:mrow><mml:msub><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mi>E</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> has <inline-formula id="inline-formula42-1740774512464831"><mml:math display="inline" id="math47-1740774512464831"><mml:mrow><mml:munderover><mml:mo>∑</mml:mo><mml:mrow><mml:mi>j</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>m</mml:mi></mml:mrow></mml:munderover><mml:munderover><mml:mo>∑</mml:mo><mml:mrow><mml:mi>k</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>p</mml:mi><mml:mo>−</mml:mo><mml:mi>j</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:munderover><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:mi>jk</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> rows. <inline-formula id="inline-formula43-1740774512464831"><mml:math display="inline" id="math48-1740774512464831"><mml:mrow><mml:msub><mml:mrow><mml:mover><mml:mrow><mml:mi>W</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>C</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> and <inline-formula id="inline-formula44-1740774512464831"><mml:math display="inline" id="math49-1740774512464831"><mml:mrow><mml:msub><mml:mrow><mml:mover><mml:mrow><mml:mi>W</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>E</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> are diagonal matrices with weights for each subject in each time period in the control and experimental condition, respectively. <inline-formula id="inline-formula45-1740774512464831"><mml:math display="inline" id="math50-1740774512464831"><mml:mrow><mml:msub><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi>jk</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> and <inline-formula id="inline-formula46-1740774512464831"><mml:math display="inline" id="math51-1740774512464831"><mml:mrow><mml:msub><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:mi>jk</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> are vectors that represent subjects from the <italic>j</italic>th accrual group in the <italic>k</italic>th time period, in the control and experimental condition, and each of these vectors has (<italic>p +</italic> 1) elements. <inline-formula id="inline-formula47-1740774512464831"><mml:math display="inline" id="math52-1740774512464831"><mml:mrow><mml:msub><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi>jk</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> has value 1 on the (<italic>j + k</italic>− 1)th position and 0 on all the other positions, while <inline-formula id="inline-formula48-1740774512464831"><mml:math display="inline" id="math53-1740774512464831"><mml:mrow><mml:msub><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:mi>jk</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> has value 1 on the (<italic>j + k</italic>− 1)th and (<italic>p +</italic> 1)th positions and 0 on all the other positions. <inline-formula id="inline-formula49-1740774512464831"><mml:math display="inline" id="math54-1740774512464831"><mml:mrow><mml:msub><mml:mrow><mml:mover><mml:mrow><mml:mi>W</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> and <inline-formula id="inline-formula50-1740774512464831"><mml:math display="inline" id="math55-1740774512464831"><mml:mrow><mml:msub><mml:mrow><mml:mover><mml:mrow><mml:mi>W</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> are scalars equal to weights <inline-formula id="inline-formula51-1740774512464831"><mml:math display="inline" id="math56-1740774512464831"><mml:mrow><mml:msub><mml:mrow><mml:mover><mml:mrow><mml:mi>w</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>C</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula> and <inline-formula id="inline-formula52-1740774512464831"><mml:math display="inline" id="math57-1740774512464831"><mml:mrow><mml:msub><mml:mrow><mml:mover><mml:mrow><mml:mi>w</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>E</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula>, which depend on the link function <italic>g</italic>. For the logit link function, they are calculated using the values of the estimated hazard probabilities <inline-formula id="inline-formula53-1740774512464831"><mml:math display="inline" id="math58-1740774512464831"><mml:mrow><mml:msub><mml:mrow><mml:mover><mml:mrow><mml:mi>h</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>C</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula> and <inline-formula id="inline-formula54-1740774512464831"><mml:math display="inline" id="math59-1740774512464831"><mml:mrow><mml:msub><mml:mrow><mml:mover><mml:mrow><mml:mi>h</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>E</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula> in the time period <italic>k</italic>: <inline-formula id="inline-formula55-1740774512464831"><mml:math display="inline" id="math60-1740774512464831"><mml:mrow><mml:msub><mml:mrow><mml:mover><mml:mrow><mml:mi>w</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>C</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mover><mml:mrow><mml:mi>h</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>C</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msub><mml:mrow><mml:mover><mml:mrow><mml:mi>h</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>C</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula> and <inline-formula id="inline-formula56-1740774512464831"><mml:math display="inline" id="math61-1740774512464831"><mml:mrow><mml:msub><mml:mrow><mml:mover><mml:mrow><mml:mi>w</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>E</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mover><mml:mrow><mml:mi>h</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>E</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msub><mml:mrow><mml:mover><mml:mrow><mml:mi>h</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>E</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula>.</p>
<p>To detect a difference between the two treatment conditions, the null hypothesis <inline-formula id="inline-formula57-1740774512464831"><mml:math display="inline" id="math62-1740774512464831"><mml:mrow><mml:msub><mml:mrow><mml:mi>H</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>: <inline-formula id="inline-formula58-1740774512464831"><mml:math display="inline" id="math63-1740774512464831"><mml:mrow><mml:mi>β</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></inline-formula> versus the alternative <inline-formula id="inline-formula59-1740774512464831"><mml:math display="inline" id="math64-1740774512464831"><mml:mrow><mml:msub><mml:mrow><mml:mi>H</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>: <inline-formula id="inline-formula60-1740774512464831"><mml:math display="inline" id="math65-1740774512464831"><mml:mrow><mml:mi>β</mml:mi><mml:mo>≠</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></inline-formula> is verified. The <italic>z-</italic>statistic <inline-formula id="inline-formula61-1740774512464831"><mml:math display="inline" id="math66-1740774512464831"><mml:mrow><mml:mi>z</mml:mi><mml:mo>=</mml:mo><mml:mover><mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover><mml:mo stretchy="false">/</mml:mo><mml:msqrt><mml:mrow><mml:mover><mml:mrow><mml:mi>Var</mml:mi></mml:mrow><mml:mo stretchy="true">^</mml:mo></mml:mover><mml:mo stretchy="false">(</mml:mo><mml:mover><mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msqrt></mml:mrow></mml:math></inline-formula>, that is, the square root of the Wald test statistic is evaluated against a standard normal distribution for this purpose. Then, the statistical power of this test, <inline-formula id="inline-formula62-1740774512464831"><mml:math display="inline" id="math67-1740774512464831"><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:mi>γ</mml:mi></mml:mrow></mml:math></inline-formula> is calculated from</p>
<p>
<disp-formula id="disp-formula6-1740774512464831">
<label>(4)</label>
<mml:math display="block" id="math68-1740774512464831">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi>z</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>1</mml:mn>
<mml:mo>−</mml:mo>
<mml:mi>γ</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo>=</mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:mrow>
<mml:mo>|</mml:mo>
<mml:mi>β</mml:mi>
<mml:mo>|</mml:mo>
</mml:mrow>
</mml:mrow>
<mml:mrow>
<mml:msqrt>
<mml:mrow>
<mml:mover>
<mml:mrow>
<mml:mi>Var</mml:mi>
</mml:mrow>
<mml:mo stretchy="true">^</mml:mo>
</mml:mover>
<mml:mo stretchy="false">(</mml:mo>
<mml:mover>
<mml:mrow>
<mml:mi>β</mml:mi>
</mml:mrow>
<mml:mo>^</mml:mo>
</mml:mover>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:msqrt>
</mml:mrow>
</mml:mfrac>
<mml:mo>−</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>z</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>1</mml:mn>
<mml:mo>−</mml:mo>
<mml:mi>α</mml:mi>
<mml:mo stretchy="false">/</mml:mo>
<mml:mn>2</mml:mn>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:math>
<graphic alternate-form-of="disp-formula6-1740774512464831" xlink:href="10.1177_1740774512464831-eq6.tif"/>
</disp-formula>
</p>
<p>where <inline-formula id="inline-formula63-1740774512464831"><mml:math display="inline" id="math69-1740774512464831"><mml:mrow><mml:mi>α</mml:mi></mml:mrow></mml:math></inline-formula> is a significant level and <inline-formula id="inline-formula64-1740774512464831"><mml:math display="inline" id="math70-1740774512464831"><mml:mrow><mml:msub><mml:mrow><mml:mi>z</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:mi>γ</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> and <inline-formula id="inline-formula65-1740774512464831"><mml:math display="inline" id="math71-1740774512464831"><mml:mrow><mml:msub><mml:mrow><mml:mi>z</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:mi>α</mml:mi><mml:mo stretchy="false">/</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> are critical values from the standard normal distribution. <inline-formula id="inline-formula66-1740774512464831"><mml:math display="inline" id="math72-1740774512464831"><mml:mrow><mml:mover><mml:mrow><mml:mi>Var</mml:mi></mml:mrow><mml:mo stretchy="true">^</mml:mo></mml:mover><mml:mo stretchy="false">(</mml:mo><mml:mover><mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula> is the entry of matrix (3) in the (<italic>p +</italic> 1)th row and (<italic>p +</italic> 1)th column.</p>
</sec>
<sec id="section9-1740774512464831">
<title>Designs</title>
<sec id="section10-1740774512464831">
<title>Survival model</title>
<p>The underlying survival functions <italic>S</italic>(<italic>t</italic>) for the control and the experimental conditions need to be known to calculate the <inline-formula id="inline-formula67-1740774512464831"><mml:math display="inline" id="math73-1740774512464831"><mml:mrow><mml:mover><mml:mrow><mml:mi>Var</mml:mi></mml:mrow><mml:mo stretchy="true">^</mml:mo></mml:mover><mml:mo stretchy="false">(</mml:mo><mml:mover><mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula>, and hence the statistical power. To find survival and hazard probabilities for both conditions, many survival distributions can be applied. For the control condition, we choose the Weibull survival distribution because it provides a very flexible hazard function. However, for the experimental condition, we do not apply any parametric survival distribution, but we calculate the hazard probabilities by adding the value of the treatment effect <italic>β</italic> on the logit scale to the hazard probabilities of the control condition.</p>
<p>The continuous-time Weibull survival function is represented as <inline-formula id="inline-formula68-1740774512464831"><mml:math display="inline" id="math74-1740774512464831"><mml:mrow><mml:mi>S</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:msup><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mo>−</mml:mo><mml:mi>λ</mml:mi><mml:msup><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>τ</mml:mi></mml:mrow></mml:msup></mml:mrow></mml:msup></mml:mrow></mml:math></inline-formula> and the corresponding hazard rate is given by <inline-formula id="inline-formula69-1740774512464831"><mml:math display="inline" id="math75-1740774512464831"><mml:mrow><mml:mi>h</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mi>λ</mml:mi><mml:mi>τ</mml:mi><mml:msup><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>τ</mml:mi><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math></inline-formula>.The parameter <inline-formula id="inline-formula70-1740774512464831"><mml:math display="inline" id="math76-1740774512464831"><mml:mrow><mml:mi>τ</mml:mi><mml:mo>∈</mml:mo><mml:mo stretchy="false">[</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mo>+</mml:mo><mml:mo>∝</mml:mo><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula> is a shape parameter and depending on <italic>τ</italic>, the risk of experiencing the event increases, decreases, or remains constant over time. For <inline-formula id="inline-formula71-1740774512464831"><mml:math display="inline" id="math77-1740774512464831"><mml:mrow><mml:mi>τ</mml:mi><mml:mspace width="0.25em"/><mml:mo>&gt;</mml:mo><mml:mspace width="0.25em"/><mml:mn>1</mml:mn></mml:mrow></mml:math></inline-formula>, the risk is concentrated toward the end of the study; for <inline-formula id="inline-formula72-1740774512464831"><mml:math display="inline" id="math78-1740774512464831"><mml:mrow><mml:mi>τ</mml:mi><mml:mspace width="0.25em"/><mml:mo>&lt;</mml:mo><mml:mspace width="0.25em"/><mml:mn>1</mml:mn></mml:mrow></mml:math></inline-formula>, it is concentrated toward the beginning of the study; and for <inline-formula id="inline-formula73-1740774512464831"><mml:math display="inline" id="math79-1740774512464831"><mml:mrow><mml:mi>τ</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math></inline-formula>, it is constant across time periods. Time <italic>t</italic> refers to the time elapsed in the study, and it is rescaled to be between 0 and 1. The value 0 represents the beginning of the trial, while 1 represents the end of the trial. The scale parameter <inline-formula id="inline-formula74-1740774512464831"><mml:math display="inline" id="math80-1740774512464831"><mml:mrow><mml:mi>λ</mml:mi><mml:mo>∈</mml:mo><mml:mo stretchy="false">[</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mo>+</mml:mo><mml:mo>∝</mml:mo><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula> is replaced by <inline-formula id="inline-formula75-1740774512464831"><mml:math display="inline" id="math81-1740774512464831"><mml:mrow><mml:mo>−</mml:mo><mml:mi>log</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:mi>ω</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula>, where <inline-formula id="inline-formula76-1740774512464831"><mml:math display="inline" id="math82-1740774512464831"><mml:mrow><mml:mi>ω</mml:mi><mml:mo>∈</mml:mo><mml:mo stretchy="false">[</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy="false">]</mml:mo></mml:mrow></mml:math></inline-formula> is the proportion of the subjects who have experienced the event after <italic>p</italic> time intervals. Using this reparameterization, the Weibull survival and hazard functions are reformulated as <inline-formula id="inline-formula77-1740774512464831"><mml:math display="inline" id="math83-1740774512464831"><mml:mrow><mml:mi>S</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:mi>ω</mml:mi><mml:msup><mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mi>τ</mml:mi></mml:mrow></mml:msup></mml:mrow></mml:math></inline-formula> and <inline-formula id="inline-formula78-1740774512464831"><mml:math display="inline" id="math84-1740774512464831"><mml:mrow><mml:mi>h</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mo>−</mml:mo><mml:mi>λ</mml:mi><mml:msup><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>τ</mml:mi><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup><mml:mi>log</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:mi>ω</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula>.</p>
<p>In our calculation, we consider various values of <italic>τ</italic>: <italic>τ</italic> = 1/4, 1/3, 1/2, 1, 2, 3, and 4, but we present our results only for <italic>τ</italic> = 1/3, 1, and 3. We take <italic>ω</italic> = 0.3, 0.5, and 0.7 to represent cases where 30%, 50%, or 70% of the subjects have experienced the event after <italic>p</italic> time intervals, and we take <italic>β</italic> = 0.25, 0.5, and 0.75 to represent small, medium, and large effect of the treatment, respectively. Moreover, we choose three different lengths of the duration of the trial <italic>p</italic>: 12, 24, and 36 time periods that may be considered as the lengths for 1, 2, and 3 years, respectively, given the time periods represent months.</p>
</sec>
<sec id="section11-1740774512464831">
<title>Results</title>
<p>In this section, we illustrate designs that are found numerically and that ensure a power level of 0.8. To reach a sufficient level of statistical power, a proper number of participants should be recruited. If the number of subjects who can enter the study in a particular length of time, that is, who belong to a particular accrual group, is small, for example, when a rare disease is investigated, more accrual groups should be included. On the other hand, if a large number of subjects per accrual group are available, fewer accrual groups should be included. Furthermore, to calculate a sufficient number of subjects, a size of the treatment effect, a proportion of subjects who have experienced the event after <italic>p</italic> periods, a survival curve, and duration of the study need to be specified. Moreover, an attrition rate can also be taken into account.</p>
<p>In <xref ref-type="fig" rid="fig2-1740774512464831">Figures 2</xref> to <xref ref-type="fig" rid="fig4-1740774512464831">4</xref>, we present our results for trials without attrition, and in <xref ref-type="fig" rid="fig5-1740774512464831">Figure 5</xref>, we take attrition into account. <xref ref-type="fig" rid="fig2-1740774512464831">Figures 2</xref> to <xref ref-type="fig" rid="fig4-1740774512464831">4</xref> show the designs with a power of 0.8 for varying accrual group sizes <italic>c</italic> (horizontal axis of each graph) and numbers of accrual groups <italic>m</italic> (vertical axis of each graph), for different values of <italic>ω</italic> = 0.3, 0.5, and 0.7 (lines within each graph), <italic>β</italic> = 0.25, 0.5, and 0.75 (columns in matrix of graphs), and <italic>τ</italic> = 3, 1, and 1/3 (rows in matrix of graphs). The illustrated curves are interpretable only for integer values of <italic>m</italic> and <italic>c</italic>. What is more, for a given combination (<inline-formula id="inline-formula79-1740774512464831"><mml:math display="inline" id="math85-1740774512464831"><mml:mrow><mml:mi>ω</mml:mi></mml:mrow></mml:math></inline-formula>, <italic>β</italic>, <italic>τ</italic>), the power is larger than 0.8 in the area above the related curve and smaller than 0.8 in the area below the curve.</p>
<fig id="fig2-1740774512464831" position="float">
<label>Figure 2.</label>
<caption>
<p>Designs with a power of 0.8 for studies with a duration of 12 periods, and varying values of the Weibull shape parameter <italic>τ</italic>, effect size <italic>β</italic>, and proportion of subjects experiencing the event at the end of study duration <italic>ω</italic> = (0.3 (dotted line), 0.5 (solid line), and 0.7 (dashed line)). The area above a line indicates power levels larger than 0.8, while the area below a line corresponds to lower power levels.</p>
</caption>
<graphic xlink:href="10.1177_1740774512464831-fig2.tif"/>
</fig>
<fig id="fig3-1740774512464831" position="float">
<label>Figure 3.</label>
<caption>
<p>Designs with a power of 0.8 for studies with a duration of 24 periods and varying values of the Weibull shape parameter <italic>τ</italic>, effect size <italic>β</italic>, and proportion of subjects experiencing the event at the end of study duration <italic>ω</italic> = (0.3 (dotted line), 0.5 (solid line), and 0.7 (dashed line)). The area above a line indicates power levels larger than 0.8, while the area below a line corresponds to lower power levels.</p>
</caption>
<graphic xlink:href="10.1177_1740774512464831-fig3.tif"/>
</fig>
<fig id="fig4-1740774512464831" position="float">
<label>Figure 4.</label>
<caption>
<p>Designs with a power of 0.8 for studies with a duration of 36 periods and varying values of the Weibull shape parameter <italic>τ</italic>, effect size <italic>β</italic>, and proportion of subjects experiencing the event at the end of study duration <italic>ω</italic> = (0.3 (dotted line), 0.5 (solid line), and 0.7 (dashed line)). The area above a line indicates power levels larger than 0.8, while the area below a line corresponds to lower power levels.</p>
</caption>
<graphic xlink:href="10.1177_1740774512464831-fig4.tif"/>
</fig>
<fig id="fig5-1740774512464831" position="float">
<label>Figure 5.</label>
<caption>
<p>Designs with a power of 0.8 for studies with a duration of 24 periods, proportion of subjects experiencing the event at the end of study duration <italic>ω</italic> = 0.5 and varying values of the Weibull shape parameter <italic>τ</italic>, effect size <italic>β</italic>, and attrition rate <italic>r</italic> = (0 (dotted line), 0.05 (solid line), and 0.1 (dashed line)). The area above a line indicates power levels larger than 0.8, while the area below a line corresponds to lower power levels.</p>
</caption>
<graphic xlink:href="10.1177_1740774512464831-fig5.tif"/>
</fig>
<p>It is observed that more subjects should be recruited per accrual group or more accrual groups are needed when <italic>β</italic> or <inline-formula id="inline-formula80-1740774512464831"><mml:math display="inline" id="math86-1740774512464831"><mml:mrow><mml:mi>ω</mml:mi></mml:mrow></mml:math></inline-formula> decreases or when <italic>τ</italic> increases. That implies that a larger sample size is needed when the effect size becomes smaller or the proportion of the subjects who have experienced the event after <italic>p</italic> periods becomes smaller. Moreover, the sample size changes when the shape of the survival curve changes. If the probability of experiencing the event is concentrated at the beginning of the study (<italic>τ</italic> &lt; 1), many subjects experience the event shortly after entering the study, and if the probability is concentrated at the end of the study (<italic>τ</italic> &gt; 1), subjects are more likely to experience the event after many time periods. In the latter case, since subjects may enter the study while the trial is being conducted, many of them do not experience the event because the time they stay in the study is too short. Therefore, the required sample size is larger in a trial with <italic>τ</italic> &gt; 1 than in a trial with <italic>τ</italic> &lt; 1. Furthermore, the differences between the designs for various <inline-formula id="inline-formula81-1740774512464831"><mml:math display="inline" id="math87-1740774512464831"><mml:mrow><mml:mi>ω</mml:mi></mml:mrow></mml:math></inline-formula> become smaller when <italic>β</italic> increases or <italic>τ</italic> decreases. For instance, in the study with <italic>p</italic> = 12, <italic>τ</italic> = 3, <italic>β</italic> = 0.25, and <italic>m</italic> = 12, the power is equal to 0.8 when <italic>c</italic> is equal to 174, 250, and 420 for <italic>ω</italic> = 0.7, 0.5, and 0.3, respectively. However, for <italic>p</italic> = 12, <italic>τ</italic> = 3, and <italic>m</italic> = 12, but for a larger value of the effect size, <italic>β</italic> = 0.5, the power is equal to 0.8 when <italic>c</italic> is equal to 42, 60, and 98 for <italic>ω</italic> = 0.7, 0.5, and 0.3, respectively. Moreover, for this larger effect size <italic>β</italic> = 0.5, if there is only one accrual group (<italic>m</italic> = 1) with many recruited subjects, the power in this case is already larger than 0.8. For example, for <italic>ω</italic> = 0.5, the power is larger than 0.8 for <italic>c</italic> &gt; 250.</p>
<p>As is mentioned earlier, the lines present designs that give a power of 0.8, but the area above/below these lines illustrates designs that give larger/smaller power than 0.8. For instance, the trial with <italic>p</italic> = 12, <italic>τ</italic> = 3, <italic>β</italic> = 0.25, <italic>ω</italic> = 0.7, and <italic>m</italic> = 12 has a power of 0.8 for <italic>c</italic> = 174, has a power &gt;0.8 for <italic>c</italic> &gt; 174, and has a power &lt;0.8 for <italic>c</italic> &lt; 174. In this way, researchers can observe whether the power increases or decreases when the chosen design departs slightly from the design with the power of 0.8.</p>
<p><xref ref-type="fig" rid="fig2-1740774512464831">Figures 2</xref> to <xref ref-type="fig" rid="fig4-1740774512464831">4</xref> illustrate designs for trials where the duration of the study varies. Respectively, a duration of <italic>p</italic> = 12, 24, and 36 time periods is taken into account. It is observed that the statistical power changes if the length of the trial changes, and in some cases, when the duration of the study is short, it may be impossible to find a design with a sufficient power level. The problem with a short duration especially occurs when the accrual group sizes are small and a large sample size is needed to reach a sufficient power level. For example, if <italic>p</italic> = 12, <italic>τ</italic> = 3, <italic>β</italic> = 0.25, <italic>m</italic> = 12, and <italic>ω</italic> = 0.7, and in each of the accrual group there are 174 subjects, the power is equal to 0.8. But if there are less than 174 subjects available in each accrual group, then the power does not reach the level of 0.8. In such cases, the duration of the study should be prolonged because then more accrual groups, and hence more subjects, can be recruited.</p>
<p>We mentioned earlier in this section that we also studied other values of <italic>τ</italic>, namely, 1/4, 1/2, 2, and 4. We have not presented the results for these values because for <italic>τ</italic> = 1/4 and 1/2, they are similar to those for <italic>τ</italic> = 1/3, and for <italic>τ</italic> = 2 and 4, they are similar to those for <italic>τ</italic> = 3. The only differences appear for <italic>τ</italic> = 2 or 4, when <italic>β</italic> = 0.25; they are the largest when <italic>p</italic> = 12, but they become smaller when the duration of the study increases. We observe that the sample size should be larger for <italic>τ</italic> = 4 than <italic>τ</italic> = 3 but smaller for <italic>τ</italic> = 2 than <italic>τ</italic> = 3.</p>
<p><xref ref-type="fig" rid="fig5-1740774512464831">Figure 5</xref> shows how the designs change when attrition is considered in the study. The attrition rate <italic>r</italic> is the proportion of subjects who leave the study between any two adjacent measurements due to unforeseen reasons, such as moving out of town or changing schools or jobs, and we only consider noninformative attrition. So, the number of subjects in each time period gets smaller, and we recalculate the numbers <inline-formula id="inline-formula82-1740774512464831"><mml:math display="inline" id="math88-1740774512464831"><mml:mrow><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi>jk</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> and <inline-formula id="inline-formula83-1740774512464831"><mml:math display="inline" id="math89-1740774512464831"><mml:mrow><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:mi>jk</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> in the following way: <inline-formula id="inline-formula84-1740774512464831"><mml:math display="inline" id="math90-1740774512464831"><mml:mrow><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi>jk</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi><mml:mo>,</mml:mo><mml:mi>k</mml:mi><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msub><mml:mrow><mml:mi>h</mml:mi></mml:mrow><mml:mrow><mml:mi>C</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:mi>r</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula> and <inline-formula id="inline-formula85-1740774512464831"><mml:math display="inline" id="math91-1740774512464831"><mml:mrow><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:mi>jk</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi><mml:mo>,</mml:mo><mml:mi>k</mml:mi><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msub><mml:mrow><mml:mi>h</mml:mi></mml:mrow><mml:mrow><mml:mi>E</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:mi>r</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula>. These numbers are then used in <xref ref-type="disp-formula" rid="disp-formula5-1740774512464831">Equation (3)</xref>. We present the designs only for a duration of 24 time periods since the influence of the attrition rate <italic>r</italic> is similar for other durations. We assume that <italic>r</italic> is constant and fixed across time periods, and we consider <italic>r</italic> = 0.05 or <italic>r</italic> = 0.1 in each time period. It is observed that when subjects leave the study due to unforeseen reasons, more accrual groups should be included or more subjects should be recruited in each accrual group. Moreover, the larger the attrition rate, larger the sample size needed. The differences in sample sizes for varying <italic>r</italic> get smaller when <italic>β</italic> increases or <italic>τ</italic> decreases, and the biggest difference is when <italic>β</italic> is small and <italic>τ</italic> is large. For instance, in the case where <italic>τ</italic> = 3, <italic>β</italic> = 0.25, and <italic>m</italic> = 24, the power is equal to 0.8 for the accrual group size <italic>c</italic> equal to 130, 246, and 454 for <italic>r</italic> = 0, 0.05, and 0.1, respectively (the curve for <italic>r</italic> = 0.1 does not fit in the scale of <xref ref-type="fig" rid="fig5-1740774512464831">Figure 5</xref>, so it is not presented here). Therefore, the influence of attrition on the power level depends on the survival function and the size of the treatment effect. When the effect size is small, or there are many subjects who experience the event after many time periods, then the differences between designs without and with attrition are very large. When many subjects experience the event shortly after entering into the study, then the differences between designs without and with attrition are very small for various sizes of the treatment effect.</p>
</sec>
</sec>
<sec id="section12-1740774512464831">
<title>An example: treatments in a first episode of psychotic illness</title>
<p>A psychotic illness is a widespread disorder in modern society. People suffering from psychosis may have, for example, hallucinations, delusions, unusual, or bizarre behavior. This illness is very often described as a ‘loss of contact with reality’, and it is difficult to treat when it has been already developed. When a person receives a treatment in the initial episodes of the illness, it may lead to clinical improvement or prevent the development of the psychosis. Thus, there are many studies on a first episode of psychosis. For instance, Schooler <italic>et al</italic>. [<xref ref-type="bibr" rid="bibr16-1740774512464831">16</xref>] present a long-term randomized trial where the effectiveness of the two antipsychotic medications, risperidone and haloperidol, is compared. The authors show that after 2 years of receiving these medicines, the risperidone prevents relapse in 58% and haloperidol in 45% of the participants.</p>
<p>We assume that there is a new medicine that is even more effective than risperidone, and we expect its effect to be equal to 0.5 on the logit scale. Researchers have 5 years to conduct the study with two equally sized treatment groups. The first treatment group receives risperidone, and the second treatment group receives the new medicine. The measurements are taken once every 2 months, so the trial consists of <italic>p</italic> = 30 time periods.</p>
<p>To be able to calculate designs, one should know the underlying survival functions. We assume the Weibull distribution with <italic>τ</italic> = 1/3 and <italic>ω</italic> = 0.52 for the control condition and obtain the hazard probabilities for the treatment condition by adding <italic>β</italic> = −0.5 on the logit scale to the hazard probabilities in the control condition. The survival functions for both conditions are presented in <xref ref-type="fig" rid="fig6-1740774512464831">Figure 6</xref>. As it is observed for the control condition, after 12 time periods, 58% of the participants and after 30 time periods, 48% of the participants have not yet experienced a relapse. For the experimental condition, after 12 time periods, 72% of the participants, and after 30 time periods, 63% of the participants have not yet experienced a relapse.</p>
<fig id="fig6-1740774512464831" position="float">
<label>Figure 6.</label>
<caption>
<p>Survival probabilities in the control (risperidone) and experimental (new treatment) groups in psychosis example.</p>
</caption>
<graphic xlink:href="10.1177_1740774512464831-fig6.tif"/>
</fig>
<p>Now, we calculate how many accrual groups and how many subjects in each accrual group should be included in the study to get a sufficient value of the statistical power. The results are presented in <xref ref-type="table" rid="table1-1740774512464831">Table 1</xref>. If there are many persons per accrual group with first symptoms of psychosis who can enter the study, then just a few accrual groups should be included. For instance, if there are 40 persons per accrual group, then just nine accrual groups should be followed over time. If there are few persons per accrual group, then more accrual groups should be included. For instance, if there are 14 persons per accrual group, then 28 accrual groups should be followed over time.</p>
<table-wrap id="table1-1740774512464831" position="float">
<label>Table 1.</label>
<caption>
<p>Designs to achieve statistical power of 0.8 for the psychosis example</p>
</caption>
<graphic alternate-form-of="table1-1740774512464831" xlink:href="10.1177_1740774512464831-table1.tif"/>
<table>
<colgroup>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Accrual group size</th>
<th align="left">Number of accrual groups</th>
</tr>
</thead>
<tbody>
<tr>
<td>14</td>
<td>28</td>
</tr>
<tr>
<td>16</td>
<td>23</td>
</tr>
<tr>
<td>18</td>
<td>20</td>
</tr>
<tr>
<td>20</td>
<td>18</td>
</tr>
<tr>
<td>22</td>
<td>16</td>
</tr>
<tr>
<td>24</td>
<td>15</td>
</tr>
<tr>
<td>26</td>
<td>14</td>
</tr>
<tr>
<td>28</td>
<td>13</td>
</tr>
<tr>
<td>30</td>
<td>12</td>
</tr>
<tr>
<td>32</td>
<td>11</td>
</tr>
<tr>
<td>34</td>
<td>10</td>
</tr>
<tr>
<td>36</td>
<td>10</td>
</tr>
<tr>
<td>38</td>
<td>9</td>
</tr>
<tr>
<td>40</td>
<td>9</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="section13-1740774512464831" sec-type="conclusions|discussion">
<title>Conclusions and discussion</title>
<p>This article studies accrual by groups in a trial with discrete-time survival endpoints and describes how to choose the number of accrual groups, the size of the accrual groups, and the duration of the trial to achieve a sufficient power level. To find a good combination of the three, the effect size, the proportion of subjects who have experienced the event after a fixed number of time periods, and the underlying survival function need to be taken into account. In our study, we consider all of these important factors, and we observe that more subjects should be recruited in each accrual group, or more accrual groups should be included, if the effect size or the proportion of subjects who have experienced the event after a fixed number of time periods decreases or the probability of the event occurrence is concentrated toward the end of the study duration. When attrition is present in the study, then even more subjects should be recruited in each accrual group or more accrual groups should be included.</p>
<p>The results of our study are presented graphically because there are no simple closed-form expressions for finding the variance of the treatment effect, but it can be calculated numerically using, for example, MATLAB software. The code we use is given in Appendix (online supplementary material). The results can also be obtained using simulation but that approach needs much more time for obtaining calculations. Our results are obtained for the case where the underlying survival function in the control condition follows the Weibull survival function, but any other survival distribution can also be applied in our approach. To choose a good survival distribution, researchers need to have some prior knowledge about the survival in a particular study, which sometimes might be difficult if there is not much information. In such cases, the survival function can be based on an educated guess or findings in the literature. Another option might be to apply a maximin optimality criterion [<xref ref-type="bibr" rid="bibr17-1740774512464831">17</xref>]. In our research, we assume the same underlying continuous-time survival function for all accrual groups, but varying survival distributions can also be used, and the designs may be different in such cases. One may expect the designs to be different from that of our study to a large extent when the variability of survival functions across accrual groups increases.</p>
<p>In model (1), any link function can be easily applied. In our calculations, we use two link functions – the logit and the complementary log–log link functions – and both the functions gave similar results. We decide to present results only for the logistic link function because of its popularity and simple interpretation as the logarithm of the odds ratio.</p>
<p>The designs that we found are based on the assumption that the accrual rate is constant across time. Pasternack and Gilbert [<xref ref-type="bibr" rid="bibr8-1740774512464831">8</xref>] and Morgan [<xref ref-type="bibr" rid="bibr12-1740774512464831">12</xref>] investigated continuous-time survival studies where the number of patients entering the trial was the same in each unit of time. However, there are cases where the accrual was nonconstant. For instance, Maki [<xref ref-type="bibr" rid="bibr18-1740774512464831">18</xref>] illustrated power and sample size for clinical trials where subjects enrolled at random time which was given by the probability density function, and the author proposed few functions that are very flexible. There are also other studies for continuous-time survival endpoints that assume nonconstant accrual of patients, so it might be worthwhile to investigate in future research the designs for trials with discrete-time survival endpoints where the accrual rate varies in different time periods.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<label>Funding</label>
<p>This research was funded by a VIDI grant from the Netherlands Organization for Scientific Research (NWO) number 452-08-004.</p>
</fn>
<fn fn-type="conflict">
<label>Conflict of interest</label>
<p>There is no conflict of interest.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-1740774512464831">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cox</surname><given-names>DR</given-names></name>
</person-group>. <article-title>Regression models and life-tables</article-title>. <source>J R Stat Soc Series B Stat Methodol</source> <year>1972</year>; <volume>34</volume>(<issue>2</issue>): <fpage>187</fpage>–<lpage>220</lpage>.</citation>
</ref>
<ref id="bibr2-1740774512464831">
<label>2.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>McCullagh</surname><given-names>P</given-names></name>
<name><surname>Nelder</surname><given-names>JA</given-names></name>
</person-group>. <source>Generalized Linear Models</source>. <publisher-name>Chapman and Hall</publisher-name>, <publisher-loc>Boca Raton, FL</publisher-loc>, <year>1983</year>.</citation>
</ref>
<ref id="bibr3-1740774512464831">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Storr</surname><given-names>CL</given-names></name>
<name><surname>Ialongo</surname><given-names>NS</given-names></name>
<name><surname>Kellam</surname><given-names>SG</given-names></name>
<name><surname>Anthony</surname><given-names>JC</given-names></name>
</person-group>. <article-title>A randomized controlled trial of two primary school intervention strategies to prevent early onset tobacco smoking</article-title>. <source>Drug Alcohol Depend</source> <year>2002</year>; <volume>66</volume>: <fpage>51</fpage>–<lpage>60</lpage>.</citation>
</ref>
<ref id="bibr4-1740774512464831">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Moerbeek</surname><given-names>M</given-names></name>
</person-group>. <article-title>Powerful and cost-efficient designs for longitudinal intervention studies with two treatment groups</article-title>. <source>J Educ Behav Stat</source> <year>2008</year>; <volume>33</volume>(<issue>1</issue>): <fpage>41</fpage>–<lpage>61</lpage>.</citation>
</ref>
<ref id="bibr5-1740774512464831">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Jozwiak</surname><given-names>K</given-names></name>
<name><surname>Moerbeek</surname><given-names>M</given-names></name>
</person-group>. <article-title>Power analysis for trials with discrete-time survival endpoints</article-title>. <source>J Educ Behav Stat</source> <year>2012</year>; <volume>37</volume>(<issue>5</issue>): <fpage>630</fpage>–<lpage>54</lpage>.</citation>
</ref>
<ref id="bibr6-1740774512464831">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Jozwiak</surname><given-names>K</given-names></name>
<name><surname>Moerbeek</surname><given-names>M</given-names></name>
</person-group>. <article-title>Cost-effective designs for trials with discrete-time survival endpoints</article-title>. <source>Comput Stat Data An</source> <year>2012</year>; <volume>56</volume>: <fpage>2086</fpage>–<lpage>96</lpage>.</citation>
</ref>
<ref id="bibr7-1740774512464831">
<label>7.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Singer</surname><given-names>JD</given-names></name>
<name><surname>Willett</surname><given-names>JB</given-names></name>
</person-group>. <source>Applied Longitudinal Data Analysis</source>. <publisher-name>Oxford University Press</publisher-name>, <publisher-loc>New York</publisher-loc>, <year>2003</year>.</citation>
</ref>
<ref id="bibr8-1740774512464831">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pasternack</surname><given-names>BS</given-names></name>
<name><surname>Gilbert</surname><given-names>HS</given-names></name>
</person-group>. <article-title>Planning the duration of long-term survival time studies designed for accrual by cohorts</article-title>. <source>J Chronic Dis</source> <year>1971</year>; <volume>24</volume>: <fpage>681</fpage>–<lpage>700</lpage>.</citation>
</ref>
<ref id="bibr9-1740774512464831">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>George</surname><given-names>SL</given-names></name>
<name><surname>Desu</surname><given-names>MM</given-names></name>
</person-group>. <article-title>Planning the size and duration of a clinical trial studying the time to some critical event</article-title>. <source>J Chronic Dis</source> <year>1974</year>; <volume>27</volume>: <fpage>15</fpage>–<lpage>24</lpage>.</citation>
</ref>
<ref id="bibr10-1740774512464831">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rubinstein</surname><given-names>LV</given-names></name>
<name><surname>Gail</surname><given-names>MH</given-names></name>
<name><surname>Santner</surname><given-names>TJ</given-names></name>
</person-group>. <article-title>Planning the duration of a comparative clinical trial with loss to follow-up and a period of continued observation</article-title>. <source>J Chronic Dis</source> <year>1981</year>; <volume>34</volume>: <fpage>469</fpage>–<lpage>79</lpage>.</citation>
</ref>
<ref id="bibr11-1740774512464831">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Schoenfeld</surname><given-names>DA</given-names></name>
<name><surname>Richter</surname><given-names>JR</given-names></name>
</person-group>. <article-title>Nomograms for calculating the number of patients needed for a clinical trial with survival as an endpoint</article-title>. <source>Biometrics</source> <year>1982</year>; <volume>38</volume>: <fpage>163</fpage>–<lpage>70</lpage>.</citation>
</ref>
<ref id="bibr12-1740774512464831">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Morgan</surname><given-names>TM</given-names></name>
</person-group>. <article-title>Planning the duration of accrual and follow-up for clinical trials</article-title>. <source>J Chronic Dis</source> <year>1985</year>; <volume>38</volume>(<issue>12</issue>): <fpage>1009</fpage>–<lpage>18</lpage>.</citation>
</ref>
<ref id="bibr13-1740774512464831">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lachin</surname><given-names>JM</given-names></name>
<name><surname>Foulkes</surname><given-names>MA</given-names></name>
</person-group>. <article-title>Evaluation of sample size and power for analysis of survival with allowance for nonuniform patient entry, losses to follow-up, noncompliance, and stratification</article-title>. <source>Biometrics</source> <year>1986</year>; <volume>42</volume>: <fpage>507</fpage>–<lpage>19</lpage>.</citation>
</ref>
<ref id="bibr14-1740774512464831">
<label>14.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Kalbfleisch</surname><given-names>JD</given-names></name>
<name><surname>Prentice</surname><given-names>RL</given-names></name>
</person-group>. <source>The Statistical Analysis of Failure Time Data</source>. <publisher-name>Wiley &amp; Sons</publisher-name>, <publisher-loc>Hoboken, NJ</publisher-loc>, <year>2002</year>.</citation>
</ref>
<ref id="bibr15-1740774512464831">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Prentice</surname><given-names>RL</given-names></name>
<name><surname>Gloeckler</surname><given-names>LA</given-names></name>
</person-group>. <article-title>Regression analysis of grouped survival data with application to breast cancer data</article-title>. <source>Biometrics</source> <year>1978</year>; <volume>34</volume>: <fpage>57</fpage>–<lpage>67</lpage>.</citation>
</ref>
<ref id="bibr16-1740774512464831">
<label>16.</label>
<citation citation-type="journal"><person-group person-group-type="author">
<name><surname>Schooler</surname><given-names>N</given-names></name>
<name><surname>Rabinowitz</surname><given-names>J</given-names></name>
<name><surname>Davidson</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Risperidone and haloperidol in first-episode psychosis: A long-term randomized trial</article-title>. <source>Am J Psychiatry</source> <year>2005</year>; <volume>162</volume>: <fpage>947</fpage>–<lpage>53</lpage>.</citation>
</ref>
<ref id="bibr17-1740774512464831">
<label>17.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tekle</surname><given-names>F</given-names></name>
<name><surname>Tan</surname><given-names>F</given-names></name>
<name><surname>Berger</surname><given-names>M</given-names></name>
</person-group>. <article-title>Maximin D-optimal designs for binary longitudinal responses</article-title>. <source>Comput Stat Data An</source> <year>2008</year>; <volume>54</volume>: <fpage>5253</fpage>–<lpage>62</lpage>.</citation>
</ref>
<ref id="bibr18-1740774512464831">
<label>18.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Maki</surname><given-names>E</given-names></name>
</person-group>. <article-title>Power and sample size considerations in clinical trials with competing risk endpoints</article-title>. <source>Pharm Stat</source> <year>2006</year>; <volume>5</volume>: <fpage>159</fpage>–<lpage>71</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>